Bad Blood: Secrets and Lies in a Silicon Valley Startup

US: Picador, 2019. Paperback. Very Good. A New York Times Bestseller Longlisted for the Financial Times and McKinsey Business Book of the Year A ward 'Chilling . . . Reads like a West Coast version of All the President's Men. ' New York Times Book Review The full inside story of the breathtaking rise and shocking collapse of The ranos, the multibillion-dollar biotech startup, by the prize-winning journa list who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the f emale Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" prom ised to revolutionize the medical industry with a machine that would make b lood testing significantly faster and easier. Backed by investors such as L arry Ellison and Tim Draper, Theranos sold shares in a fundraising round th at valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. In Bad Blood, John Carreyrou tells the riveting story of the biggest corpor ate fraud since Enron, a tale of ambition and hubris set amid the bold prom ises of Silicon Valley. Now to be adapted into a film, with Jennifer Lawrence to star.